|
CCT8 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.119000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.074400E-01 |
| Normal-vs-Stage2 |
7.860600E-01 |
| Normal-vs-Stage3 |
2.524400E-01 |
| Normal-vs-Stage4 |
1.419590E-01 |
| Stage1-vs-Stage2 |
8.473600E-01 |
| Stage1-vs-Stage3 |
8.666400E-02 |
| Stage1-vs-Stage4 |
6.124100E-02 |
| Stage2-vs-Stage3 |
2.812800E-01 |
| Stage2-vs-Stage4 |
1.061750E-01 |
| Stage3-vs-Stage4 |
5.548200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.261200E-01 |
| Normal-vs-AfricanAmerican |
2.172000E-01 |
| Normal-vs-Asian |
2.507600E-01 |
| Caucasian-vs-AfricanAmerican |
2.727600E-02 |
| Caucasian-vs-Asian |
2.062400E-01 |
| AfricanAmerican-vs-Asian |
1.377030E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.554400E-01 |
| Normal-vs-Female |
5.904400E-02 |
| Male-vs-Female |
4.276400E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.167400E-01 |
| Normal-vs-Extreme_Weight |
6.019600E-02 |
| Normal-vs-Obese |
2.036400E-01 |
| Normal-vs-Extreme_Obese |
1.226600E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.596000E-02 |
| Normal_Weight-vs-Obese |
4.499000E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.501700E-02 |
| Extreme_Weight-vs-Obese |
7.221500E-03 |
| Extreme_Weight-vs-Extreme_Obese |
2.901800E-01 |
| Obese-vs-Extreme_Obese |
4.936300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.619850E-01 |
| Normal-vs-Age(41-60Yrs) |
8.540800E-01 |
| Normal-vs-Age(61-80Yrs) |
4.791000E-01 |
| Normal-vs-Age(81-100Yrs) |
7.500000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.761970E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.088230E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.356000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.552600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.822580E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.379000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.709550E-01 |
| Normal-VS-Type2 PRCC |
5.692000E-01 |
| Normal-VS-KIRP CIMP |
3.789999999948E-06 |
| Normal-VS-Unclassified PRCC |
2.108800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
7.783700E-02 |
| Type1 PRCC-VS-KIRP CIMP |
8.4344000000014E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
7.890400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.761400E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
1.212010E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.90889999999566E-05 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.053400E-01 |
| Normal-vs-N1 |
3.356300E-03 |
| Normal-vs-N2 |
4.239200E-01 |
| N0-vs-N1 |
8.621700E-04 |
| N0-vs-N2 |
5.129200E-01 |
| N1-vs-N2 |
3.271200E-01 |
|
|
